Exelixis Inc (NASDAQ: EXEL) kicked off on Monday, up 0.93% from the previous trading day, before settling in for the closing price of $43.67. Over the past 52 weeks, EXEL has traded in a range of $21.82-$49.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 11.55%. While this was happening, its average annual earnings per share was recorded 51.04%. With a float of $263.89 million, this company’s outstanding shares have now reached $275.03 million.
The extent of productivity of a business whose workforce counts for 1147 workers is very important to gauge. In terms of profitability, gross margin is 96.78%, operating margin of 33.15%, and the pretax margin is 36.45%.
Exelixis Inc (EXEL) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Exelixis Inc is 3.23%, while institutional ownership is 92.62%. The most recent insider transaction that took place on Jun 02 ’25, was worth 805,140. In this transaction Director of this company sold 18,838 shares at a rate of $42.74, taking the stock ownership to the 21,380 shares. Before that another transaction happened on Jun 03 ’25, when Company’s Director sold 7,535 for $43.09, making the entire transaction worth $324,683. This insider now owns 358,882 shares in total.
Exelixis Inc (EXEL) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 51.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.33% during the next five years compared to 11.55% growth over the previous five years of trading.
Exelixis Inc (NASDAQ: EXEL) Trading Performance Indicators
Take a look at Exelixis Inc’s (EXEL) current performance indicators. Last quarter, stock had a quick ratio of 3.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.23. Likewise, its price to free cash flow for the trailing twelve months is 14.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.20, a number that is poised to hit 0.64 in the next quarter and is forecasted to reach 3.18 in one year’s time.
Technical Analysis of Exelixis Inc (EXEL)
The latest stats from [Exelixis Inc, EXEL] show that its last 5-days average volume of 4.16 million was superior to 2.97 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 38.50%.
During the past 100 days, Exelixis Inc’s (EXEL) raw stochastic average was set at 67.84%, which indicates a significant increase from 43.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.29% in the past 14 days, which was higher than the 45.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.02, while its 200-day Moving Average is $35.32. Now, the first resistance to watch is $44.55. This is followed by the second major resistance level at $45.02. The third major resistance level sits at $45.56. If the price goes on to break the first support level at $43.54, it is likely to go to the next support level at $43.00. Assuming the price breaks the second support level, the third support level stands at $42.53.
Exelixis Inc (NASDAQ: EXEL) Key Stats
The company with the Market Capitalisation of 12.02 billion has total of 272,708K Shares Outstanding. Its annual sales at the moment are 2,169 M in contrast with the sum of 521,270 K annual income. Company’s last quarter sales were recorded 555,450 K and last quarter income was 159,620 K.
